New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 19, 2013
04:55 EDTLIFE, LIFE, LIFE, SI, SI, SI, BIOL, BIOL, BIOL, IVC, IVC, IVC, VAR, VAR, VAR, ARAY, ARAY, ARAY, CPHD, CPHD, CPHD, MASI, MASI, MASI, HRC, HRC, HRC, RHHBY, RHHBY, RHHBY, MCK, MCK, MCKWorldwide Business Research to host a conference
Field Service Medical Conference is being held in San Diego on February 19-21.
News For LIFE;RHHBY;HRC;MASI;CPHD;ARAY;VAR;IVC;BIOL;SI;MCK From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 >>
February 1, 2016
06:08 EDTHRCHill-Rom sees Q2 adjusted EPS 68c-70c, consensus 77c
Subscribe for More Information
06:06 EDTHRCHill-Rom reports Q1 adjusted EPS 68c, consensus 65c
Reports Q1 revenue $661M, consensus $659.52M.
January 31, 2016
16:13 EDTRHHBYGenentech receives orphan designation for Avastin in mesothelioma
Subscribe for More Information
January 29, 2016
16:21 EDTLIFEaTyr Pharma appoints John Blake CFO
Subscribe for More Information
January 28, 2016
16:12 EDTARAYAccuray backs FY16 revenue view of $395M-$410M, consensus $404.6M
Adjusted EBITDA is expected to range between $25M-$35M. Accuray continues to expect that gross orders for the fiscal year will be approximately $295M, which would represent a 10% increase year over year. This financial guidance is unchanged from that provided on January 11.
16:11 EDTARAYAccuray reports Q2 EPS (8c), consensus (8c)
Subscribe for More Information
05:48 EDTRHHBYRoche expects 2016 sales to grow low- to mid-single digit
Subscribe for More Information
05:48 EDTRHHBYRoche board recommends dividend increase to CHF 8.10 per share
Subscribe for More Information
05:47 EDTRHHBYRoche reports FY15 core EPS CHF 13.49 vs. CHF 14.29 last year
05:46 EDTRHHBYRoche reports FY15 Group sales CHF 44.15B vs. CHF 47.46B last year
Subscribe for More Information
05:37 EDTRHHBYAbbVie announces venetoclax granted Breakthrough Therapy Designation by FDA
Subscribe for More Information
January 27, 2016
16:18 EDTMCKMcKesson sees FY17 adjusted EPS to grow 7%--12% excluding items
McKesson expects growth in adjusted EPS for FY17 to be between 3% and 8%, as reported, and between 7% and 12%, excluding 48c of gains on the disposition of two businesses and favorable discrete tax items in FY16.
16:17 EDTMCKMcKesson backs FY16 adjusted EPS $12.60-$12.90, consensus $12.77
Subscribe for More Information
16:16 EDTMCKMcKesson reports Q3 adjusted EPS $3.18, consensus $3.13
Reports Q3 revenue $47.9B, consensus $48.8B.
16:06 EDTVARVarian Medical sees FY16 EPS $4.55-$4.65, consensus $4.47
Subscribe for More Information
16:05 EDTVARVarian Medical sees Q2 EPS $1.06-$1.10, consensus $1.12
Subscribe for More Information
16:04 EDTVARVarian Medical reports Q1 EPS 99c, consensus 94c
Reports Q1 revenue $757.1M, consensus $746.56M.
14:34 EDTMCKNotable companies reporting after market close
Notable companies reporting after the market close, with earnings consensus, include Facebook (FB), consensus 68c... Qualcomm (QCOM), consensus 90c... Texas Instruments (TXN), consensus 69c... McKesson (MCK), consensus $3.13... PayPal (PYPL), consensus 35c... Las Vegas Sands (LVS), consensus 65c... eBay (EBAY), consensus 50c... Crown Castle (CCI), consensus $1.10... Vertex (VRTX), consensus 17c... Discover (DFS), consensus $1.30... SanDisk (SNDK), consensus 89c... ServiceNow (NOW), consensus 8c... Lam Research (LRCX), consensus $1.43... Citrix Systems (CTXS), consensus $1.19... Hologic (HOLX), consensus 42c... Juniper (JNPR), consensus 59c... Cavium (CAVM), consensus 28c... Cirrus Logic (CRUS), consensus 81c.
12:19 EDTRHHBYPiper Jaffray biopharma analyst holds an analyst/industry conference call
Subscribe for More Information
09:02 EDTRHHBYEli Lilly and Roche to collaborate on Alzheimer's diagnostic tool
Subscribe for More Information
1 | 2 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use